Cancer incidence in first-generation migrants and host populations in seven European registries, including Ukrainian-born migrants in Poland: a population-based study

Background: Where people are born shapes their cancer risk, yet European cancer surveillance rarely records migration background. We estimated cancer incidence in first-generation migrants and assessed whether birth-country incidence stratifies their cancer risk. Methods: We harmonised data from six population-based cancer registries in Belgium, the Netherlands, Spain (Murcia, Tarragona), Italy (Turin), and Switzerland (Ticino) for 2003 to 2017, examining breast, colorectal, cervical, stomach, liver, and lung cancer in first-generation migrants and host populations. Countries of birth were grouped into quartiles of GLOBOCAN age-standardised incidence by cancer site and sex (birth-country incidence categories). We estimated cumulative risks (CR) and migrant-to-host cumulative risk ratios (CRR). Ukrainian-born migrants in Poland were analysed separately for 2022 and 2023. Findings: The cancer risk among individuals with a migration background increased with birth-country incidence for cervical, stomach, and liver cancer. For cervical cancer, CRR rose from close to 1 in migrants from low-incidence countries to 4,9 (95% CI 3,5-6,9) in those from high-incidence countries in Turin. Breast and colorectal cancer diagnosis risk was lower than in host populations in every category. Across the six cancers combined, migrants had lower risk in 9 of 11 registry and sex strata, as lower breast, colorectal, and lung cancer risk outweighed higher cervical, stomach, and liver cancer risk. Ukrainian-born migrants in Poland (n=4450) had higher CR at most anatomical sites than the host population. Interpretation: The cancer risk among individuals with a migration background relative to host populations depends on country of birth and cancer site. Birth-country incidence is a useful way of grouping migrants by risk. National averages can mask residual risk in subgroups, e.g. migrants born in high-incidence countries had up to five times the cervical cancer risk of host populations with rates near or below the WHO elimination threshold. Routine recording of country of birth can support risk-tailored prevention and cancer service planning for displaced populations.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-10-28
DOI
https://doi.org/10.64898/2026.10.26.26366426
Primary Topic
Global Cancer Incidence and Screening
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Cancer incidence in first-generation migrants and host populations in seven European registries, including Ukrainian-born migrants in Poland: a population-based study

Alberto Ameijide, Koen Van Herck, Lorenzo Richiardi, Catharina J. Alberts et al.
1 links
medRxiv
Global Cancer Incidence and Screening
preprint

Cancer incidence in first-generation migrants and host populations in seven European registries, including Ukrainian-born migrants in Poland: a population-based study

Alberto Ameijide, Koen Van Herck, Lorenzo Richiardi, Catharina J. Alberts, Jaume Galcerán, Enrica Migliore, Urszula E. Wojciechowska, Laura Ortelli, Freija Verdoodt, Otto J. Visser, Joanna Aleksandra Didkowska, Iacopo Baussano, Irene Man, Freddie Bray, Andrea Gini, María Dolores Chirlaque López, Damien Georges, Andrea Bordoni, Stefano Rosso, Antonia Sánchez Gil, Armien Lanssens, Maria Carulla Areste
preprint en

Abstract

Background: Where people are born shapes their cancer risk, yet European cancer surveillance rarely records migration background. We estimated cancer incidence in first-generation migrants and assessed whether birth-country incidence stratifies their cancer risk. Methods: We harmonised data from six population-based cancer registries in Belgium, the Netherlands, Spain (Murcia, Tarragona), Italy (Turin), and Switzerland (Ticino) for 2003 to 2017, examining breast, colorectal, cervical, stomach, liver, and lung cancer in first-generation migrants and host populations. Countries of birth were grouped into quartiles of GLOBOCAN age-standardised incidence by cancer site and sex (birth-country incidence categories). We estimated cumulative risks (CR) and migrant-to-host cumulative risk ratios (CRR). Ukrainian-born migrants in Poland were analysed separately for 2022 and 2023. Findings: The cancer risk among individuals with a migration background increased with birth-country incidence for cervical, stomach, and liver cancer. For cervical cancer, CRR rose from close to 1 in migrants from low-incidence countries to 4,9 (95% CI 3,5-6,9) in those from high-incidence countries in Turin. Breast and colorectal cancer diagnosis risk was lower than in host populations in every category. Across the six cancers combined, migrants had lower risk in 9 of 11 registry and sex strata, as lower breast, colorectal, and lung cancer risk outweighed higher cervical, stomach, and liver cancer risk. Ukrainian-born migrants in Poland (n=4450) had higher CR at most anatomical sites than the host population. Interpretation: The cancer risk among individuals with a migration background relative to host populations depends on country of birth and cancer site. Birth-country incidence is a useful way of grouping migrants by risk. National averages can mask residual risk in subgroups, e.g. migrants born in high-incidence countries had up to five times the cervical cancer risk of host populations with rates near or below the WHO elimination threshold. Routine recording of country of birth can support risk-tailored prevention and cancer service planning for displaced populations.

medRxiv
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Institut de Recerca Biomèdica Catalunya Sud (ES), Netherlands Comprehensive Cancer Organisation (NL), Instituto Murciano de Investigación Biosanitaria (ES), GGD Amsterdam (NL), Hospital Universitari Sant Joan de Reus (ES), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Piedmont Reference Center for Epidemiology and Cancer Prevention (IT), Amsterdam University Medical Centers (NL), Centre international de recherche sur le cancer (FR)
ZonMw
Good health and well-being, Reduced inequalities
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon